REALM Bio

🌍At REALM Bio, we’re on the verge of something truly transformative. Our 1REALM platform was built from the belief that every person, no matter where they live, should have access to advanced therapies that could save or change their lives. While cell and gene therapies are at the cutting edge of medicine, access to these life-saving treatments is still limited for millions, especially in underserved communities worldwide. REALM Bio isn’t just closing the gap—we’re erasing it. This is more than a launch for us; it’s a mission to bring equity and hope to healthcare. In the coming weeks, we’ll introduce you to our pioneering 1REALM platform, our strategy for global access, and the incredible global partners that are bringing this vision to life. Welcome to REALM Bio.

🚀 Exciting news from REALM Bio: We’re approaching our next funding milestone! #JPM2025 was an incredible success, opening doors to key partnerships, valuable contacts, and exciting funding opportunities. We gained invaluable insights at the non-dilutive funding event— perfect timing as we just onboarded 9 talented Northeastern University M.S. in Biotech and Regulatory Affairs interns to support our (non-federal) grant writing and research efforts. Huge shout out to Aanshal Patel, Audrey Lou, Khushi P. Priya Babariya, Riya Patel, Eesha M, Shruti Lone, Stuti Desai, and Vidhisha Savaliya We have an exciting announcement ahead as we advance our mission to make cell and gene therapies accessible worldwide—reaching rural and suburban communities around the globe. Here’s to making innovation equitable! 🌟 #REALMBio #JPM2025 #CellAndGeneTherapy #HealthEquity

🌟 We Are Hiring: Cell and Gene Therapy Business Development Leader 🌟 REALM Bio is on the brink of launching something pioneering. 🚀 With a surge of interest and opportunities, we are seeking a seasoned professional to lead our Business Development efforts. If you’re a business development expert with a talent for identifying and managing opportunities, bring your network and join us on this inspired journey. We are still operating under the radar, but we are preparing to introduce the world to our 1REALM United Services Platform, which will globalize access to advanced therapies. Understanding the importance of providing global underserved patient populations with access to cell, gene, and CAR-T therapies, whether clinical or commercial, is what inspires us. If you share this vision, connect with us to learn about our platform and how you can join our inspired mission. www.realm.bio/bd Even if you're not actively looking, keep an eye on us. We’re on the brink of something groundbreaking and we can't wait to show you. Visit WWW.REALM.Bio and reserve your invitation to our upcoming live event, where we will soon introduce the world to our infant Hercules. Let’s make history together. 🌍✨ #REALMBio #BizDev #HealthcareInnovation

Have you had a chance to explore our recent whitepapers? Would you like to revisit the ones that caught your attention? Over the last four weeks, we published four whitepapers looking at a different aspect of how #DecentralizedManufacturing of cell and gene therapies can be achieved and used to increase accessibility for rural and global communities. You can read the entire series here: www.realm.bio/insights A BIG thank you to everyone who collaborated with us and helped to create this series! Domhnall Mc Gowan, Erika Francoeur, Craig Hasilo, Jenny Ligon, Stephen Stewart, and Enayat Mohammad, PMP

🌍 Our fourth white paper, 'Beyond Urban Centers: Expanding CAR-T Therapy with Decentralized Manufacturing,' addresses a vital challenge – extending the reach of life-saving CAR-T therapies beyond metropolitan hubs. This paper highlights our commitment to globalizing access to advanced medical treatments through decentralization.   Learn more about how our 1REALM platform is set to enhance #GlobalHealth by making personalized medicines accessible everywhere. www.realm.bio   #CARTherapy #HealthEquity #InnovationInHealthcare 

🌟 Launching the third installment of our insightful white paper series! 'Building a Sustainable Workforce for Decentralized Manufacturing: Perspectives from The Industry' examines the crucial element of human capital in the expansion of #decentralizedmanufacturing. Discover how industry leaders are developing the skills and teams necessary to sustain innovation and growth in the manufacture of advanced therapies, all integral to our 1REALM platform's success. www.realm.bio A massive thank you to Craig Hasilo, Jenny Ligon, and Stephen Stewart for their contribution to this paper. #pointofcare #WorkforceDevelopment #ATMP #GMPtraining  

🚀 Our second white paper in the series dives into the #EmergingTechnologies shaping the future of #AutologousTherapies. Titled 'Enabling Decentralized Manufacturing of Autologous Advanced Therapy Products: A Review of Emerging Technologies,' this paper explores how innovations are paving the way for accessible, personalized treatment options right at the #pointofcare. www.realm.bio   Follow us to find out on how these advancements integrate with our upcoming 1REALM platform, revolutionizing #globalaccess to healthcare.   #Biotech #HealthcareInnovation #decentralizedmanufacturing 

Here we go... Excited to introduce Realm Bio! (www.realm.bio) We're on a mission to globalize equal access to advanced therapies. Our 1Realm unified services platform brings the foundational services supporting the entire ATMP process together, right at the point of care, worldwide. Stay tuned for updates on our inspired journey to erase the gap in access to these life-changing therapies. #HealthcareInnovation #GlobalAccess #RealmBio

🎉We are pleased to announce the start of our white paper series chronicling #decentralizedmanufacturing at the #pointofcare.    This first white paper titled Decentralized Manufacturing: Improving Access to Cell and Gene Therapies and Removing Barriers to Global Markets will begin a series of introductions leading to the launch of our new #ATMP logistics and manufacturing platform, 1REALM, that will soon redefine #globalaccess to personalized medicines.   #CGT #innovation #biotechnology #biomedicalscience https://lnkd.in/eRU5z2rv